News | February 28, 2012

Boston Scientific Announces First Implants of Teligen ICD in China

Boston Scientific Corp. announces the first implants of a Teligen implantable cardioverter-defibrillator (ICD) in China. The implants were performed by Farong Shen, M.D., in Zhejiang Hospital, Hangzhou and Wei Hua, M.D., in Fuwai Hospital, Beijing. The Teligen family of ICDs, designed to treat sudden cardiac death, are the smallest and thinnest high-energy devices available in China. They offer extended battery longevity over previous Boston Scientific ICDs currently approved in China, as well as improved programming technology to offer patients enhanced clinical options. The Teligen family of devices was approved by the State Food and Drug Administration (SFDA) of the People's Republic of China in November 2011.

"These new ICDs feature significant advances and will be a welcome technology for Chinese patients requiring implantable defibrillators," said Shu Zhang, M.D., chairman of the Chinese Society of Pacing and Electrophysiology.

"Boston Scientific is committed to providing innovative products and therapies to Chinese physicians and their patients," said Joe Fitzgerald, senior vice president and president of the Cardiac Rhythm Management group at Boston Scientific. "We believe [this] first implant of our advanced ICDs, combined with our recent launch of the Promus Element Plus Coronary Stent System in China, positions Boston Scientific for future growth in this important market."

The company estimates annual market growth exceeding 15 percent over the next five years. In July 2011, Boston Scientific announced a five-year, $150 million investment in China to expand its commercial presence and support the establishment of a local, wholly owned manufacturing facility focused on serving Chinese market needs and developing a world-class training center for Chinese healthcare providers.

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Overlay Init